SPR Therapeutics® Secures $25 Million in Series C Financing
SPR Therapeutics® Secures $25 Million in Series C Financing
Funding will support commercialization of SPRINT® PNS System, a non-opioid neurostimulation pain-relief therapy for chronic and acute …